Wageningen University & Research
Wageningen, Gelderland, Netherlands
NCT Number: NCT05762965
Within the Denali study the effect of 3 weeks intervention with GOS on the abundance of Bifidobacterium in faecal samples will be investigated.
Looking for future studies?
Notify Me40 year–70 year
Female
Interventional
Not applicable
Wageningen, Gelderland, Netherlands
This randomized, parallel, double-blinded intervention study of 6 weeks will include 88 females, who will consume GOS for three consecutive weeks. Faecal samples will be collected at several time points to measure microbiota composition.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
1 sachet each morning
Other names: galacto oligosaccharide
1 sachet each morning
Other names: galacto oligosaccharide
Time frame: At week -3 (start control)
faecal abundance of Bifidobacterium.
Time frame: At week 0 (end control)
faecal abundance of Bifidobacterium.
Time frame: At week 3 (end intervention)
faecal abundance of Bifidobacterium.
Time frame: At week -3 (start control)
Gene-based microbiota profiling of faecal samples
Time frame: At week 0 (end control)
Gene-based microbiota profiling of faecal samples
Time frame: At week 3 (end intervention)
Gene-based microbiota profiling of faecal samples
Wageningen University and Research
Other
Acronym: Denali
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05765422
Communicable Diseases, Disease Attributes
Nice, France
View Trial DetailsNCT07092046
Anesthesia Circuit, Anesthesia Equipment Bacterial Contamination
Ankara, Turkey (Türkiye)
View Trial DetailsNCT07045636
Communicable Diseases, Digestive System Diseases
Guarulhos, São Paulo, Brazil
View Trial DetailsNCT05065671
Communicable Diseases, Disease Attributes
Somerville, New Jersey, United States
View Trial Details